Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(9%)
Results Posted
50%(4 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_4
4
36%
Ph phase_2
6
55%
Ph phase_3
1
9%

Phase Distribution

0

Early Stage

6

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
6(54.5%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
4(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
unknown1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 26 (54.5%)
Phase 31 (9.1%)
Phase 44 (36.4%)

Trials by Status

unknown19%
completed873%
terminated19%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11